Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer

Colorectal cancer is a common malignant tumor that ranks third in incidence and second in mortality worldwide, and surgery in conjunction with chemotherapy and radiotherapy remains the most common treatment option. As a result of radiotherapy’s severe side effects and dismal survival rates, it is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yi, Wang, Zehua, Zhou, Fengmei, Chen, Chen, Qin, Yanru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561929/
https://www.ncbi.nlm.nih.gov/pubmed/36248998
http://dx.doi.org/10.3389/fonc.2022.987302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561929/
https://www.ncbi.nlm.nih.gov/pubmed/36248998
http://dx.doi.org/10.3389/fonc.2022.987302

Ejemplares similares